This inventor holds 85 USPTO granted patents and 38 published patent applications, plus 9 CIPO patents and 17 EPO patents, primarily in Cannabinoid Receptor Modulators (CPC class A61K31-497). Top assignees: Arena Pharmaceuticals, Inc., University of Utah Research Foundation, Cognetix, Inc.. Active years: 1976-2024.
Inventors with similar research interests:
Location History:
- Fullerton, CA (US) (1976 - 1978)
- Cape Coral, FL (US) (1990)
- Attleboro, MA (US) (1995)
- Norton, MA (US) (2003 - 2005)
- Brooksville, FL (US) (2009 - 2012)
- Salt Lake City, UT (US) (2001 - 2013)
- San Mateo, CA (US) (2020 - 2022)
- San Diego, CA (US) (2006 - 2023)
- South San Francisco, CA (US) (2020 - 2024)
Company Filing History:
45 out of 218 
9 out of 1,685 
7 out of 10 
Years Active: 1976-2024
Areas of Expertise:
Title: Robert M. Jones: A Pioneer in Cannabinoid Research
Introduction
Robert M. Jones, based in San Diego, CA, is a distinguished inventor with an impressive portfolio of 78 patents. His innovative research primarily focuses on cannabinoid receptor modulators, particularly in the context of treating serious conditions such as cancer and pain.
Latest Patents
Among his latest patents, Robert M. Jones has developed groundbreaking methods for the treatment of cancer that involve administering compounds known as Formula Ia. These pharmaceutical compositions have been shown to effectively modulate the activity of the cannabinoid CB receptor, marking a significant advance in cancer therapeutics. Additionally, he has also worked on cannabinoid receptor modulators aimed at pain management, utilizing similar methodologies to enhance patient care and comfort.
Career Highlights
Throughout his career, Robert has made significant contributions while working at notable companies, including Arena Pharmaceuticals, Inc. His drive for innovation and his dedication to research have positioned him as a leader in the field of cannabinoid research.
Collaborations
Robert M. Jones has collaborated with esteemed colleagues such as Yifeng Xiong and Baldomero M. Olivera. These partnerships have fostered a dynamic research environment, paving the way for the advancement of cannabinoid-related therapies.
Conclusion
With his extensive patent portfolio and substantial contributions to cannabinoid research, Robert M. Jones continues to impact the fields of medicine and pharmacology significantly. His commitment to developing innovative solutions for complex medical issues underscores his importance as an inventor and researcher in the industry.